Additionally, exosomal EpCAM expression is elevated in prostate cancer patients compared to that in healthy controls [104] and has been identified as a biomarker in blood samples from pancreatic and breast cancer patients [105], where it also serves as a therapeutic target. Here, EPCAM is linked to prostate cancer.